Project Grant R21NS135041

Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $445K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research to understand human brain development and the origins of neurodevelopmental diseases. The $1,008,977 award, with a performance period from December 2024 to November 2032, will support the study of primary human brain tissue and human stem cell-derived in...
This $1,550,682 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to understand the mechanisms controlling central nervous system (CNS) myelin sheath length and their implications for neurological disorders. The primary objective is to determine how axon diameter serves as an instructive cue that triggers oligodendrocyte...
This $440,275 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will support research to systematically discover upstream regulators of the OLIG2 transcription factor, which plays a central role in the myelination of the central nervous system (CNS) by oligodendrocytes. The 2-year project aims to determine the in vivo role of the MEF2D...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $614,009 to support research focused on understanding the molecular mechanisms involved in oligodendrocyte myelination and remyelination. The goal is to identify critical factors that promote myelin production and overcome inhibitory signals, with the aim of improving myelin repair...
This Project Grant award of $481,250.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in specific neuron subtypes and contexts. The award to President and Fellows of Harvard College will enable the investigation of subcellular mechanisms controlling neural...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $173,695 to Brandeis University to support research on the regulatory mechanisms that translate neuronal activity patterns into specific gene expression programs in a defined neuron type. The goal is to systematically describe how the duration of temperature experience is...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), supports research to characterize the role of the transcription factor BMAL1 in oligodendrocyte precursor cell (OPC) differentiation and myelination. The $251,370 award to The Leland Stanford Junior University, effective August 1, 2024 through June 30, 2026, will enable the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $270,434 to The Trustees of Princeton University to investigate the role of spatiotemporal regulation of mRNA in neuronal remodeling during morphogenesis. The research will leverage Drosophila mushroom body and dendritic arborization neurons as models to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $147,656.00 to Duke University for research investigating human-specific splicing regulation in neurogenesis and disease. The research aims to define a novel mechanism of action for human-specific non-coding genome regions in regulating post-transcriptional RNA processing...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,282,359.00 to support research on the regulation of generation and functions of intermediate progenitors in neural stem cell lineages. The 5-year project, starting on July 1, 2024 and running through May 31, 2029, will be conducted by the Regents of the University of Michigan....

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $444,599 to investigate the impact of neuronal activity on oligodendrocyte progenitor cell differentiation and myelination. The research aims to characterize transcriptome changes in oligodendrocyte progenitor cells when cortical neuronal activity is manipulated using designer receptors. A $50,000 sub-award to Bioinformatic Solutions LLC will support the bioinformatic analysis of the single-cell RNA sequencing data. The project will run from July 1, 2024 to June 30, 2026, and the findings may advance understanding of the role of axonal signaling in regulating oligodendrocyte development, with potential implications for neurological disorders.

Generated 6/24/25, 3:10 AM